What is BRKR's health score?

BRUKER CORP (BRKR) has a TradeApes health score of 57 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BRKR's estimated fair value?

Based on our 5-year discounted cash flow model, BRUKER CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BRKR undervalued or overvalued?

Our model currently rates BRKR as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

BRUKER CORP (BRKR)

Healthcare Inconclusive inconclusive mixed

$58.66

Updated: 2026-07-16

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

76 Strong

Relative Value

30 Weak

Capital Allocation

55 Mixed

Risk Management

80 Strong

Key Findings

+ Strong interest coverage — EBIT covers interest 10×+

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) Alamar Biosciences, Inc. (ALMR) ASTROTECH Corp (ASTC) Avantor, Inc. (AVTR) BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) BIO-RAD LABORATORIES, INC. (BIO)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.